Emmaus Life Sciences, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Selected Financial Statement - Assets

Selected Financial Statement - Assets

6 Months Ended

Jun. 30, 2025

Balance Sheet Related Disclosures [Abstract]

Selected Financial Statement - Assets

NOTE 4 — SELECTED FINANCIAL STATEMENT — ASSETS

Inventories consisted of the following (in thousands):


	June 30, 2025			December 31, 2024
Raw materials and components	$	1,145		$	1,147
Work-in-process		186			184
Finished goods		5,010			5,328
Inventory reserve		(5,028	)		(5,024	)
Total inventories, net	$	1,313		$	1,635

Prepaid expenses and other current assets consisted of the following (in thousands):


	June 30, 2025		December 31, 2024
Prepaid insurance	$	389	$	622
Prepaid expenses		136		272
Other current assets		220		226
Total prepaid expenses and other current assets	$	745	$	1,120

Property and equipment consisted of the following (in thousands):


	June 30, 2025			December 31, 2024
Equipment	$	463		$	357
Leasehold improvements		16			15
Furniture and fixtures		30			30
Total property and equipment		509			402
Less: accumulated depreciation		(366	)		(356	)
Total property and equipment, net	$	143		$	46

For the three months ended June 30, 2025 and June 30, 2024, depreciation expense was approximately $4,000 and $6,000, respectively. For six months ended June 30, 2025 and June 30, 2024, depreciation expenses was approximately $9,000 and $12,000, respectively.